TY - JOUR T1 - Demethoxycurcumin Promotes Macrophage Cell Population and Phagocytosis in WEHI-3 Cell-generated Leukemia BALB/c Mice <em>In Vivo</em> JF - In Vivo JO - In Vivo SP - 3253 LP - 3260 DO - 10.21873/invivo.12620 VL - 35 IS - 6 AU - YI-JIA LIN AU - CHIUNG-JU CHEN AU - SHU-CHING HSUEH AU - MEI-HUI LEE AU - SHU-FEN PENG AU - HSU-FENG LU AU - KUNG-WEN LU AU - WEN-WEN HUANG AU - KUO-CHING LIU AU - YUNG-LIANG CHEN AU - YUNG-LUEN SHIH AU - JIN-CHERNG LIEN Y1 - 2021/11/01 UR - http://iv.iiarjournals.org/content/35/6/3253.abstract N2 - Background/Aim: Demethoxycurcumin (DMC), one of the components of curcuminoids, has antitumor activities in many human cancer cells and is known to induce apoptosis in human leukemia cells. However, there are no reports showing the effects of DMC on the immune response in leukemia mice in vivo. Herein, we evaluated the impact of DMC on immune responses in WEHI-3-generated leukemia mice in vivo. Materials and Methods: Fifty male BALB/c mice were separated randomly into five groups. Group I is normal mice, and groups II-V mice of generated leukemia by WEHI-3 cells. Group II-V mice were intraperitoneally injected with dimethyl sulfoxide (DMSO, as the positive control), 15, 30, and 60 mg/kg of DMC, respectively, every two days for 14 days. The body weight, blood, peritoneal fluid, liver, and spleen were individually analyzed. Results: DMC did not significantly affect animal appearance and body weight. It decreased liver and spleen weight at a high dose. DMC did not affect the cluster of differentiation 3 (CD3) and CD19 cell populations but induced decrease of CD11b at 30 mg/kg treatment. However, DMC at low dose significantly increased the cluster of macrophage (Mac-3) cell populations, but at high dose it decreased them. DMC increased macrophage phagocytosis from peripheral blood mononuclear cells at 15 mg/kg treatment and peritoneal cavity at 15, 30 and 60 mg/kg of DMC treatments. DMC did not significantly affect the cytotoxic activity of natural killer (NK) cells. Furthermore, DMC decreased B and T cell proliferation at high doses. Conclusion: DMC elevated macrophage phagocytosis in leukemia mice in vivo. ER -